Zhu, Y.; Peng, W.; Liu, G.; Li, L.; Zhou, Z.; Nguyen, M.; Robert, A.; Liu, Y.; Meunier, B.
TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice. Pharmaceutics 2025, 17, 1237.
https://doi.org/10.3390/pharmaceutics17091237
AMA Style
Zhu Y, Peng W, Liu G, Li L, Zhou Z, Nguyen M, Robert A, Liu Y, Meunier B.
TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice. Pharmaceutics. 2025; 17(9):1237.
https://doi.org/10.3390/pharmaceutics17091237
Chicago/Turabian Style
Zhu, Yingshan, Weiling Peng, Guangwei Liu, Longxin Li, Zikang Zhou, Michel Nguyen, Anne Robert, Yan Liu, and Bernard Meunier.
2025. "TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice" Pharmaceutics 17, no. 9: 1237.
https://doi.org/10.3390/pharmaceutics17091237
APA Style
Zhu, Y., Peng, W., Liu, G., Li, L., Zhou, Z., Nguyen, M., Robert, A., Liu, Y., & Meunier, B.
(2025). TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice. Pharmaceutics, 17(9), 1237.
https://doi.org/10.3390/pharmaceutics17091237